InMed Pharmaceuticals (INM) Cash from Investing Activities (2019 - 2024)
InMed Pharmaceuticals (INM) posted Cash from Investing Activities of -$2.0 for Q1 2024, up 99.99% on a QoQ basis from -$33606.0 in Q2 2023, and up 100.0% year-over-year from -$1.0 in Q2 2023.
Powered by 
Analysis
InMed Pharmaceuticals (INM) Cash from Investing Activities (2019 - 2024) Analysis & Trends
InMed Pharmaceuticals has reported Cash from Investing Activities for 6 years, with the latest figure at -$2.0 in Q1 2024.
- On a quarterly basis, Cash from Investing Activities rose 100.0% year-over-year to -$2.0 in Q1 2024; TTM through Jun 2024 was -$161806.0, a 81.84% increase from a year earlier, with the FY2024 full-year figure at -$9293.0, up 98.6% from the prior year.
- Cash from Investing Activities was -$2.0 for Q1 2024 at InMed Pharmaceuticals, up from -$33606.0 in the prior quarter.
- The five-year high for Cash from Investing Activities was $306011.0 in Q4 2021, with the low at -$725457.0 in Q2 2022.
- Average Cash from Investing Activities over 5 years is -$93631.9, with a median of -$8800.0 recorded in 2020.
- The sharpest annual moves came in 2023 and 2024: Cash from Investing Activities tumbled 3508.16% in 2023, then soared 100.0% in 2024.
- Over 5 years, Cash from Investing Activities stood at $918.0 in 2020, then jumped by 33234.53% to $306011.0 in 2021, then tumbled by 337.07% to -$725457.0 in 2022, then soared by 95.37% to -$33606.0 in 2023, then soared by 99.99% to -$2.0 in 2024.
- The last three Cash from Investing Activities figures came in at -$2.0 (Q1 2024), -$33606.0 (Q2 2023), and -$128198.0 (Q1 2023), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Corning | 145.18 Bn | 142.67 Bn | 1.63 Bn | -359.00 Mn |
| 2 | Ati | 28.28 Bn | 27.50 Bn | 309.80 Mn | -63.20 Mn |
| 3 | Qnity Electronics | 26.28 Bn | 25.32 Bn | 666.00 Mn | -82.00 Mn |
| 4 | International Flavors & Fragrances | 21.50 Bn | 20.93 Bn | 853.00 Mn | -156.00 Mn |
| 5 | DuPont de Nemours | 17.40 Bn | 15.66 Bn | 639.00 Mn | 1.09 Bn |
| 6 | Avery Dennison | 12.97 Bn | 12.74 Bn | 729.40 Mn | -117.80 Mn |
| 7 | Solstice Advanced Materials | 10.03 Bn | 9.28 Bn | 370.00 Mn | -138.00 Mn |
| 8 | Element Solutions | 8.73 Bn | 8.54 Bn | 334.00 Mn | -29.40 Mn |
| 9 | Eastman Chemical | 7.82 Bn | 7.13 Bn | 560.00 Mn | -99.00 Mn |
| 10 | InMed Pharmaceuticals | 5.30 Mn | 61,528.56 | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2024 | -2.00 |
| Jun 30, 2023 | -33,606.00 |
| Mar 31, 2023 | -128,198.00 |
| Jun 30, 2022 | -725,457.00 |
| Mar 31, 2022 | -3,553.00 |
| Dec 31, 2021 | 306,011.00 |
| Sep 30, 2021 | -250,000.00 |
| Jun 30, 2020 | 918.00 |
| Mar 31, 2020 | -8,800.00 |
| Dec 31, 2019 | 54,912.00 |
| Sep 30, 2019 | 3.74 Mn |